help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malarkey, W. B.
Right arrow Articles by DeGroff, V. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malarkey, W. B.
Right arrow Articles by DeGroff, V. L.

Journal of Clinical Endocrinology & Metabolism, Vol 64, 713-717, Copyright © 1987 by Endocrine Society

ARTICLES

Angiotensin II promotes prolactin release from normal human anterior pituitary cell cultures in a calcium-dependent manner

WB Malarkey, BJ Zvara and VL DeGroff

Renin and angiotensin II (AII) have been demonstrated in the mammalian central nervous system, and AII has been found to promote PRL release in the rat and monkey. We added AII to monolayer cultures of human anterior pituitary cells and found significant PRL release by 30 min with concentrations of AII as low as 10(-10) M. This AII-induced PRL release was inhibited by the specific AII antagonist saralasin. AII- induced PRL release was a calcium-dependent process, since the calcium channel blockers verapamil and nifedipine as well as the calcium- calmodulin antagonist R2471 significantly inhibited AII-induced PRL release. Prostaglandins E2, A2, and F2 alpha also inhibited AII-induced PRL release. The significance of this latter observation is not clear, however, as indomethacin, an inhibitor of the cyclo-oxygenase prostaglandin metabolic pathway, had no effect on AII-induced PRL release. In light of recent immunohistochemical evidence of the presence of renin, angiotensinogen, and converting enzyme in human lactotrophs, our data support the concept that AII may be an important autocrine regulator of PRL secretion.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. G. Iglesias, G. Diaz-Torga, V. Lux-Lantos, C. Libertun, and D. Becu-Villalobos
Calcium influx and intracellular stores in angiotensin II stimulation of normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E455 - E463.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
G. Diaz-Torga, A. G. Iglesias, R. Achaval-Zaia, C. Libertun, and D. Becu-Villalobos
Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary cells
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E534 - E540.
[Abstract] [Full Text] [PDF]

Home page
 ANGIOLOGYHome page
I. Saito, E. Takeshita, S. Hayashi, T. Takenaka, M. Murakami, T. Saruta, S. Nagano, and T. Sekihara
Effect of Captopril on Plasma Prolactin in Patients with Essential Hypertension
Angiology, May 1, 1990; 41(5): 377 - 381.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1987 by The Endocrine Society